Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAPEF.L Regulatory News (APEF)

  • There is currently no data for APEF

Interim Management Statement

14 Aug 2014 10:10

RNS Number : 1324P
Aberdeen Private Equity Fund Ltd
14 August 2014
 



14 August 2014

Aberdeen Private Equity Fund Limited

Unaudited Interim Management Statement - 3 months to 30 June 2014

To the shareholders of Aberdeen Private Equity Fund Limited

This interim management statement has been produced solely to provide additional information to shareholders as a body to meet the relevant requirements of the UK Listing Authority's Disclosure and Transparency Rules. It should not be relied upon by any other party or for any other purpose.

This interim management statement relates to the period from 1 April to 30 June 2014, and contains information that covers this period and up to the publication date for this interim management statement, unless otherwise specified.

Overview

Aberdeen Private Equity Fund Limited ("the Company") is a Guernsey closed-ended investment company listed on the London Stock Exchange. The principal investment focus of the Company is to invest in private equity and private equity-like funds.

Investment Objective and Policy

The investment objective of the Company is to generate long-term capital gains, through investment in a diversified portfolio of private equity funds. The Company may also hold direct holdings as an ancillary part of its portfolio, in hedge funds, other speciality funds, unquoted companies and unquoted securities, including fixed-interest securities, cash-equivalent investments and cash.

Material Events

On 8 July 2014, the Company released its Annual Financial Report for the year ended 31 March 2014.

The Company was admitted as a subscriber on 30 April 2014 into The Resolute Fund III, L.P. with a commitment amount of USD 15 million. The Resolute Fund III, L.P is a US mid-market buyout fund.

The Company was admitted as a subscriber on 21 July 2014 into CCMP Capital Investors III, L.P. with a commitment amount of USD 15 million. CCMP Capital Investors III, L.P is a US mid-market fund.

The Company was admitted as a subscriber on 21 July 2014 into CCMP Co-Invest III A, L.P. with a commitment amount of USD 1.5 million. CCMP Co-Invest III A, L.P. is a co-investment fund which was involved in the acquisition of Hillman Group.

Portfolio News

The Company's total commitments were $285.1 million as at 30 June 2014. The net drawn down on commitments made was approximately $205.5 million as at 30 June 2014. There were 28 capital calls made during the quarter with an aggregate amount of $8.0 million. The Company has received gross distributions, including return of excess capital called, of $155.7 million since inception. The Company received $8.6 million in distributions during the quarter. 23 revaluations were received during the quarter, 13 were upwards revaluations and 10 were downwards revaluations

The portfolio's commitment cover was 45.2% at the end of June 2014.

Portfolio Holdings as at 30 June 2014

%

Northzone VI LP

7.6

Thomas H Lee Parallel Fund VI LP

7.4

Tenaya Capital V LP

6.5

Lion Capital Fund III LP

5.2

Silver Lake Partners III LP

5.2

Thoma Bravo IX Fund LP

4.9

Pine Brook Capital Partners LP

4.5

RHO Ventures VI LP

4.5

StepStone International Investors III LP (formerly known as Greenpark International Investors III LP)

3.9

HIG Bayside Debt & LBO Fund II LP

3.8

MatlinPatterson Global Opportunities Partners III LP

3.7

Gores Capital Partners III LP

3.6

Coller International Partners V LP

3.3

Longreach Capital Partners Ireland 1, L.P.

2.9

Goldman Sachs Capital Partners VI LP

2.8

Resonant Music LP

2.2

OCM Opportunities Fund VIIb (Cayman) Ltd

1.7

Tenaya Capital VI LP

1.6

Apax VIII

1.5

Longreach Capital Partners 2 - USD, L.P.

1.1

DFJ Athena LP

0.9

Pangaea Two Parallel L.P.

0.9

Pinebridge Latin America Partners II LP

0.3

CVC Capital Partners Asia Pacific IV LP

0.2

Resolute Fund III LP

0.0

Co-investments

1.9

Cash

17.9

 

Total Investments

 

100.0

 

Total Number of Investments

 

28

 

Cash: The Company currently invests its cash with counterparties that appear on Aberdeen Asset Managers Limited's approved lending list.

 

Geographical Allocation as at 30 June 2014

%

North America

71.9

Europe

18.8

Asia / Oceania

6.9

Latin America & Other

2.4

 

Total

 

100.0

 

General Description of Company's Financial Position as at 30 June 2014

Sterling Share NAV: 106.16 pence

Market Capitalisation: £91.3 million

As described in the Company's prospectus, and as has been the case since its launch, the net asset value ("NAV") and the NAV per share are both calculated monthly by the Company's administrator based on the latest published NAV for each underlying fund.

Investments in underlying funds for the month ended 30 June 2014 are typically valued using the values (whether final or estimated) as advised by their managers, general partners or administrators. The Company therefore relied on valuation and reporting methods used by the managers, general partners or administrators of the underlying funds in deriving the 30 June 2014 NAV and NAV per share. It is possible, from time to time, that if there is good cause to reduce the valuation of a portfolio holding, the Board, in conjunction with the manager, will do so accordingly.

Benchmark

The Company does not currently have a benchmark. Due to the nature of the Company's investments, there are no meaningful indices against which to compare the performance of the Company.

Performance (%)

Cumulative Performance

 

As at

30/06/2014

1 month

%

3 months

%

6 months

%

1 year

%

3 years

%

5 years

%

Share Price (GBP)

83.6p

1.4

6.9

8.3

0.1

28.3

72.0

NAVA (GBP)

106.2p

(2.1)

(4.0)

5.5

(2.3)

14.0

39.0

NAVA (USD)

180.6c

(0.2)

(1.5)

8.9

10.2

21.4

44.3

 

Discrete Performance (GBP)

 

Year Ended:

30/06/2014

30/06/2013

30/06/2012

30/06/2011

30/06/2010

Share Price

0.1

50.0

(14.5)

34.1

0.0

NAVA

(2.3)

6.9

9.1

8.4

12.5

 

Total Return; NAV to NAV, Net Income Reinvested, GBP. Share price total return is on a mid-to-mid basis.

Source: Aberdeen Asset Managers Limited, Lipper and Morningstar.

A Including current year revenue.

Dividend calculations are to reinvest as at the ex-dividend date. NAV returns based on NAVs with debt valued at fair value.

Past performance is not a guide to future results.

The Board is not aware of any other significant events or transactions which have occurred between 1 April 2014 and the publication date of this interim management statement which would have a material impact on the financial position of the Company.

For latest performance information, please refer to the Company's factsheet at:

http://www.aberdeenprivateequity.co.uk/doc.nsf/Lit/FactsheetUKClosedAberdeenPrivateEquityFund*

* Neither the content of the Company's website nor the content of any website accessible from hyperlinks on the Company's website (or any other website) is (or is deemed to be) incorporated into, or forms (or is deemed to form) part of this announcement.

Please note that past performance is not necessarily a guide to the future and that the value of investments and the income from them may fall as well as rise. Investors may not get back the amount they originally invested.

For Aberdeen Private Equity Fund LimitedIpes (Guernsey) LimitedCompany Secretary

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSGGUBURUPCUBC
Date   Source Headline
15th Sep 20172:00 pmRNSResult of AGM
1st Sep 20173:54 pmRNSPortfolio Listing, July 2017
30th Aug 20171:24 pmRNSNet Asset Value, July 2017
27th Jul 20174:29 pmRNSPortfolio Listing, June 2017
26th Jul 201711:56 amRNSNet Asset Value, June 2017
12th Jul 20177:00 amRNSPosting of Annual Report and AGM Notice
7th Jul 20173:45 pmRNSPortfolio Listing, May 2017
4th Jul 20173:28 pmRNSNet Asset Value, May 2017
26th Jun 20174:05 pmRNSAnnual Financial Report
26th Jun 201711:21 amRNSPortfolio Listing, April 2017
23rd Jun 201710:01 amRNSHolding(s) in Company
23rd Jun 20179:50 amRNSHolding(s) in Company
21st Jun 20174:35 pmRNSHolding(s) in Company
14th Jun 20172:00 pmRNSNet Asset Value, April 2017
12th Jun 20173:54 pmRNSHolding(s) in Company
19th May 20174:59 pmRNSCompliance with Market Abuse Regulations
10th May 201712:11 pmRNSPortfolio Listing, March 2017
5th May 20171:57 pmRNSNet Asset Value, March 2017
26th Apr 20172:11 pmRNSHolding(s) in Company
25th Apr 20174:01 pmRNSHolding(s) in Company
21st Apr 20173:19 pmRNSHolding(s) in Company
21st Apr 20171:23 pmRNSHolding(s) in Company
3rd Apr 20175:01 pmRNSPortfolio Listing, February 2017
30th Mar 20177:00 amRNSNet Asset Value, February 2017
21st Mar 20179:51 amRNSDirector/PDMR Shareholding
15th Mar 20171:19 pmRNSDirector/PDMR Shareholding
2nd Mar 20179:19 amRNSPortfolio Listing, January 2017
27th Feb 20179:25 amRNSNet Asset Value, January 2017
1st Feb 20174:25 pmRNSPortfolio Listing, December 2016
27th Jan 20177:00 amRNSNet Asset Value(s)
23rd Dec 201612:00 pmRNSPortfolio Listing, November 2016
23rd Dec 201610:29 amRNSNet Asset Value, November 2016
20th Dec 20162:15 pmRNSPosting of Half Year Report
12th Dec 20164:55 pmRNSDividend Declaration - Correction
9th Dec 20167:05 amRNSAppointment of Broker
9th Dec 20167:00 amRNSHalf-year Report
2nd Dec 20163:47 pmRNSPortfolio Update
1st Dec 201612:35 pmRNSNet Asset Value, October 2016
4th Nov 20165:08 pmRNSProhibited Period Announcement
25th Oct 20164:07 pmRNSPortfolio Listing, September 2016
25th Oct 201611:37 amRNSDirector Declaration
25th Oct 201611:32 amRNSNet Asset Value, September 2016
4th Oct 20163:32 pmRNSPortfolio Listing, August 2016
3rd Oct 20163:57 pmRNSNet Asset Value - August 2016
21st Sep 20162:11 pmRNSDirector/PDMR Shareholding
13th Sep 201611:52 amRNSResult of AGM
25th Aug 20163:29 pmRNSPortfolio Listing, July 2016
24th Aug 20169:51 amRNSNet Asset Value(s)
28th Jul 201610:48 amRNSPortfolio Listing, June 2016
28th Jul 20167:00 amRNSNet Asset Value, June 2016

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.